Stock comparison
Albemarle
ALB$13.99BMaterials Market cap, Sector
Emerald Resources NL
EMR.AX$3.46BMaterials Market cap, Sector
Overall winner
Emerald Resources NL
ALB 07 EMR.AX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
ALB0wins
7winsEMR.AX
19F
B79
36F
A89
37F
B84
58D
B76
0F
D46
20F
B78
19F
B76
Side-by-side metrics
| Metric | ALB | EMR.AX |
|---|---|---|
| Market cap | Winner: $13.99B | $3.46B |
| P/E (TTM) | Winner: - | 37.2x |
| EV/EBIT | 235.3x | 18.7x Winner |
| ROIC (TTM) | 2.24% | 16.99% Winner |
| Gross margin | 18.53% | 56.84% Winner |
| Net margin | -4.24% | 20.35% Winner |
| Revenue CAGR 5y | 11.49% | 27.74% Winner |
| EPS CAGR 5y | Winner: 31.71% | 16.38% |
| Debt / Equity | 0.2x | 0.0x Winner |
| Dividend yield | 0.9% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
ALB leads on
- P/E (TTM)-vs 37.2x+141%
- Market cap$13.99Bvs $3.46B+75%
- EPS CAGR 5y31.71%vs 16.38%+48%
EMR.AX leads on
- Net margin20.35%vs -4.24%+121%
- EV/EBIT18.7xvs 235.3x+92%
- ROIC (TTM)16.99%vs 2.24%+87%
- Debt / Equity0.0xvs 0.2x+82%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.